Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases

Journal of the Medical Association of Thailand

Volumn 97, Issue 5, 2014, Pages 540-547

  Teerasamit, Wanwarang ^a   Saiviroonporn, Pairash ^a   Pongpaibul, Ananya ^a   Korpraphong, Pornpim ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic liver disease; Cirrhosis; Double contrast; Hepatocellular carcinoma; Magnetic resonance imaging; SPIO

Indexed keywords

ALPHA FETOPROTEIN; GADODIAMIDE; GADOLINIUM PENTETATE MEGLUMINE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DOUBLE CONTRAST NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; HEPATIC ADENOMA; HEPATOBILIARY SYSTEM TUMOR; HISTOLOGY; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER INJURY; LIVER NODULE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; CONTRAST MEDIA; DEXTRANS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84902777414     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, et al. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol 2008; 191: 529-36.
2. Vogl TJ, Hammerstingl R, Schwarz W, Mack MG, Muller PK, Pegios W, et al. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198: 881-7.
3. Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000; 216: 154-62.
4. Kim YK, Kwak HS, Han YM, Kim CS. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. J Comput Assist Tomogr 2007; 31: 702-11.
5. Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, et al. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 2009; 44: 311-21.
6. Korpraphong P, Leyendecker JR, Hildebolt CF, Narra V, Bae KT, Brown JJ. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease. J Med Assoc Thai 2009; 92: 548-55.
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30.
8. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32: 205-12.
9. Park G, Kim YK, Kim CS, Yu HC, Hwang SB. Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine. Br J Radiol 2010; 83: 1010-6.
10. Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of superparamagnetic iron oxideenhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 2004; 182: 1217-23.
11. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, et al. Hepatocellular carcinoma: detection with gadolinium-and ferumoxidesenhanced MR imaging of the liver. Radiology 2002; 222: 73-80.
12. Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium-and ferumoxidesenhanced MR imaging. AJR Am J Roentgenol 1999; 172: 1547-54.
13. Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72 (Suppl 1): 2-15.
14. Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010; 105: 599-609.